A Phase I Study Of 2-Hydroxyoleic Acid (2-Ohoa), A Novel Sphingomyelin Synthase Activator In Patients (Pt) With Advanced Solid Tumors (Ast) Including Refractory High Grade Gliomas/Glioblastomas (Gbm): Updated Results Of The Expansion
JOURNAL OF CLINICAL ONCOLOGY（2016）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要